Lineage Cell Therapeutics, Inc.LCTXNYSE
Loading
Net Margin Over TimeContracting
Percentile Rank64
Studio
Year-over-Year Change

Net income as a percentage of revenue

Latest
-436.47%
↑ 49% vs avg
Percentile
P64
Within normal range
Streak
1 yr
Consecutive declineContracting
Average
-849.08%
Historical baseline
PeriodValueYoY Change
TTM-436.47%-122.8%
2024-195.90%+18.4%
2023-240.20%-34.4%
2022-178.69%+83.8%
2021-1104.18%+58.7%
2020-2671.28%-237.2%
2019-792.22%+75.6%
2018-3247.88%-191.4%
2017-1114.73%-174.8%
20161490.76%-